GENE ONLINE|News &
Opinion
Blog

SARS-CoV-2
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Antibody Treatment for Multiple Varieties of CoronaVirus
2022-08-16
Novel Inhalable COVID-19 Therapeutic Targeting Viral Replication
2022-08-10
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30
If It Works, Replicate It: Generic COVID-19 Drugs
2022-03-28
FDA Gives Emergency Approval for Lilly’s Anti-Omicron Antibody Treatment
2022-02-14
New Study Suggests Vaccines Protect against Long COVID
2022-01-28
Concerns Remain as Kintor Pharma’s Proxalutamide Shows Unbelievably High Efficacy Against Covid-19 Infections in Phase 3 Trials
2022-01-16
Pfizer’s COVID-19 Oral Antiviral Cuts Hospitalization and Death By 89%
2021-11-05
New Study Supports Llama Nanobodies As Potential COVID-19 Treatment
2021-09-23
Pfizer/BioNTech’s COVID-19 Vaccine Notches Full Approval from USFDA
2021-08-23
This CRISPR-Based Test Can Detect COVID-19 Variants From Your Spit
2021-08-13
Reprogrammed CRISPR Tool Could Target Emerging SARS-CoV-2 Variants
2021-07-28
Korea Receives 700,000 COVID-19 Vaccines from Israel Under a Swap Deal
2021-07-06
FDA Authorizes Pfizer/BioNTech’s COVID-19 Vaccine for 12 to 15 Year Olds
2021-05-11
1 2 3 9
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top